GetTopicDetailResponse(id=d20420941ef, topicName=丙肝藥物Epclusa, introduction=丙肝藥物Epclusa, content=null, image=null, comments=2, allHits=1037, url=https://h5.medsci.cn/topic?id=20941, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=101906, tagList=[TagDto(tagId=101906, tagName=丙肝藥物Epclusa)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1941153, encodeId=00da19411536a, content=<a href='/topic/show?id=d20420941ef' target=_blank style='color:#2F92EE;'>#丙肝藥物Epclusa#</a>, objectTitle=吉利德的丙肝藥物Epclusa在兒童感染患者中應(yīng)答率超過90%，喜獲FDA批準(zhǔn), objectType=article, longId=190494, objectId=01b81904941b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b81904941b, replyNumber=0, likeNumber=94, createdTime=2020-10-20, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b81904941b, moduleTitle=吉利德的丙肝藥物Epclusa在兒童感染患者中應(yīng)答率超過90%，喜獲FDA批準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=01b81904941b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941152, encodeId=8157194115204, content=<a href='/topic/show?id=d20420941ef' target=_blank style='color:#2F92EE;'>#丙肝藥物Epclusa#</a>, objectTitle=EMA支持批準(zhǔn)兩種丙肝藥物Epclusa和Zepatier, objectType=article, longId=69658, objectId=bcea69658f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcea69658f0, replyNumber=0, likeNumber=0, createdTime=2016-07-03, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcea69658f0, moduleTitle=EMA支持批準(zhǔn)兩種丙肝藥物Epclusa和Zepatier, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bcea69658f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
